Cerity Partners
CDLX icon

Cerity Partners’s Cardlytics CDLX Stock Holding History

Cerity Partners’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-170
Closed -$216K – 692
2021
Q2 		$216K Sell
170
-20
-11% -$22.6K ﹤0.01% 662
2021
Q1 		$208K Sell
190
-40
-17% -$52.8K ﹤0.01% 652
2020
Q4 		$328K Buy
+230
New +$245K 0.01% 496

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Cerity Partners's CDLX Position: Q3 2021 in Review

Cerity Partners sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 170 shares — an estimated $216K sold.

Cerity Partners first reported a position in CDLX in Q4 2020 and held it in 3 quarters. The position peaked at $328K in Q4 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Cerity Partners reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Cerity Partners sold 170 Cardlytics shares in Q3 2021, an estimated $216K.
  • Cerity Partners first reported a position in Cardlytics in Q4 2020 and held it in 3 quarters.
  • Cerity Partners's Cardlytics position peaked at $328K in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Cerity Partners's 13F filing for Q3 2021, filed 25 Oct 2021.